07:26 EDT GeneDx (WGS) files automatic mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx reports Q3 adjusted EPS 49c, consensus 42c
- GeneDx raises FY25 revenue view to $425M-$428M from $400M-$415M
- WGS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Apple upgraded, Rivian downgraded: Wall Street’s top analyst calls
- GeneDx granted breakthrough device designation for whole genome, exome tests